Santhera Pharmaceuticals Holding AG (SWX:SANN)

Switzerland · Delayed Price · Currency is CHF

15.26

+0.08 (0.53%)

Oct 2, 2026, 1:53 PM CET

SWX:SANN Financials Overview

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	101.5	77.19	39.12	103.41	7.47	-1.6
Revenue Growth	31.50%	97.32%	-62.17%	1283.84%	-	-
Gross Profit	41.6	15.17	23.58	100.18	3.88	-5.36
Operating Income	-8.73	-37.61	-33.15	51.16	-45.77	-56.89
Net Income	-31.93	-49.24	-41.97	54.78	-71.08	-55.53
Earnings Per Share	-2.31	-3.78	-3.69	5.01	-11.67	-16.25
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Asia	6.52	12.79	1.92	11.19	-
North America	46.29	11.35	98.09	-	-
Europe	24.38	14.97	3.4	-3.72	-1.6
Total	77.19	39.12	103.41	7.47	-1.6

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	41.77	22.44	40.93	30.37	1.35	21.21
Total Debt	41.28	48.95	40.62	21.55	44.44	42.98
Net Cash (Debt)	0.49	-26.51	0.31	8.82	-43.08	-21.77
Net Cash Growth	-	-	-96.54%	-	-	-
Net Cash Per Share	0.04	-2.04	0.03	0.81	-7.07	-6.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	0.66	-34.76	-35.53	47.27	-29.84	-37.36
Capital Expenditures	-0.02	-0.05	-0.15	-0.09	-0.05	-0
Free Cash Flow	0.64	-34.82	-35.68	47.18	-29.9	-37.36
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	40.98%	19.66%	60.29%	96.87%	51.93%	-
Operating Margin	-8.60%	-48.73%	-84.75%	49.47%	-612.42%	-
Pretax Margin	-31.32%	-63.55%	-106.51%	53.01%	-944.95%	3430.53%
Profit Margin	-31.46%	-63.79%	-107.30%	52.97%	-951.10%	-
FCF Margin	0.63%	-45.11%	-91.21%	45.62%	-400.05%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	1.65	-	-
Forward PE	-	1.62	1.62	1.62	105.14	105.14
P/FCF Ratio	362.79	-	-	1.91	-	-
PS Ratio	2.29	2.18	4.28	0.87	10.08	-35.00